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678Routine use of completion imaging after
infrainguinal bypass is not associated with higher
bypass graft patency
Tze-Woei Tan, MD,a Denis Rybin, PhD,b Jeffrey A. Kalish, MD,b Gheorghe Doros, PhD,b
Naomi Hamburg, MD,b Andres Schanzer, MD,c Jack L. Cronenwett, MD,d and Alik Farber, MD,b on
behalf of theVascular StudyGroupofNewEngland, Shreveport, La; Boston andWorcester,Mass; andLebanon,NH
Background: Signiﬁcant variability exists in completion imaging (CIM) after infrainguinal lower extremity bypass (LEB).
We evaluated the use of CIM and compared graft patency in patients treated by surgeons who performed routine CIM vs
those who performed selective CIM.
Methods: We reviewed the Vascular Study Group of New England database (2003-2010) and assessed the use of CIM
(angiography or duplex ultrasound) among patients undergoing LEB. The surgeon-speciﬁc CIM strategy was categorized
as routine ($80% of LEBs) vs selective (<80% of LEBs). Exclusion criteria included acute limb ischemia, bilateral pro-
cedures, and surgeon volume <10 cases per study period. Primary graft patency at discharge and at 1 year was analyzed on
the basis of CIM use and surgeon-speciﬁc CIM strategy. Multivariable analyses were performed using Poisson regression.
Results: Among 2032 LEB procedures performed by 48 surgeons, CIM was used in 1368 cases (67.3%). CIM was per-
formed in 72% of autogenous LEBs and 52% of prosthetic grafts. Dialysis (odds ratio [OR], 1.7; 95% conﬁdence interval
[CI], 1.1-2.6; P[ .01), elective LEB (OR, 2.6; 95% CI, 1.4-4.8; P[ .002), great saphenous vein conduit (OR, 2.0; 95%
CI, 1.6-2.5; P < .001), and tibial or pedal target artery (OR, 1.8; 95% CI, 1.4-2.3; P < .001) were associated with CIM
use. In multivariate models, CIM was not associated with improved primary graft patency at discharge (OR, 1.1; 95% CI,
0.7-1.7; P [ .64) or at 1 year (OR, 0.9; 95% CI, 0.7-1.2; P [ .47). Sixteen surgeons (33%) were routine users and 32
(67%) were selective users of CIM. Among patients of routine vs selective CIM users, primary graft patency at discharge
and at 1 year was 96% vs 94% (P [ .21) and 68% vs 72% (P [ .09), respectively. In multivariate analysis, routine or
selective CIM strategy was not associated with improved discharge (rate ratio, 0.8; 95% CI, 0.6-1.1; P [ .31) or 1-year
(rate ratio, 1.1; 95% CI, 0.9-1.2; P [ .56) graft patency.
Conclusions: In our observational cohort, CIM does not improve short-term and 1-year bypass graft patency in
infrainguinal LEB. The surgeon-speciﬁc strategy of selective CIM after LEB has outcomes comparable to those of routine
CIM. (J Vasc Surg 2014;60:678-85.)Infrainguinal lower extremity bypass (LEB) is an
important treatment strategy in patients with symptomatic
peripheral arterial disease who are at reasonable surgical risk
and have a suitable bypass conduit.1,2 A signiﬁcant portion
of patients treated with LEB experience early bypass graft
failure secondary to intraoperative technical problems.3-5
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://dx.doi.org/10.1016/j.jvs.2014.03.004(CIM) (angiography or duplex ultrasound) to intraopera-
tively evaluate technical adequacy of the LEB.6-11 CIM en-
ables the surgeon to identify and therefore to correct
technical defects in a timely manner, which may lead to
improvement in bypass graft patency.7,8,12-14
There is evidence that CIM is effective in detecting
technical problems during LEB4,5,10,11,13 and is therefore
valuable in such cases. Although the rationale for selective
CIM use is indisputable, the role for routine CIM use is
less clear.15 Furthermore, some authors contend that
not all defects seen on completion angiography are clini-
cally signiﬁcant and therefore do not affect long-term
bypass outcomes.16,17 Others have suggested that contin-
uous waveform Doppler is the best indicator for technical
errors and that CIM should be used selectively when
continuous waveform Doppler suggests a potential prob-
lem.15 Finally, routine CIM has been shown to lead to
unnecessary surgical re-exploration in clinically satisfactory
grafts, therefore leading to increased operating time and
resource use.17
The purpose of this study was to use a large, prospec-
tively collected database to evaluate the effect of CIM on
outcomes after LEB. We also studied LEB outcomes of
surgeons on the basis of their strategy of routine vs selective
use of CIM.
Fig 1. Use of completion imaging (CIM) after lower extremity
bypass (LEB) among surgeons within the Vascular Study Group of
New England (VSGNE).
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Patients. Our study cohort included patients who un-
derwent infrainguinal LEB by participants of the Vascular
Study Group of New England (VSGNE). This cooperative
quality improvement initiative was developed in 2002 to
prospectively study regional outcomes of patients undergo-
ing vascular surgery. The details of this registry have been
previously published18 and are available online at http://
www.vsgne.org. The Institutional Review Board at Bos-
ton University School of Medicine has approved the use of
the de-identiﬁed data for this study.
There were 3554 LEB procedures performed for clau-
dication and critical limb ischemia by 71 surgeons in aca-
demic and community hospitals within VSGNE between
2003 and 2010. In this cohort, the bypass inﬂow origin
included the common femoral artery, profunda femoris ar-
tery, superﬁcial femoral artery, and above- or below-knee
popliteal artery. Target outﬂow arteries included the above-
or below-knee popliteal artery, tibioperoneal trunk, and
tibial or pedal vessels. Conduits used included in situ saphe-
nous vein, reversed vein, nonreversed vein, arm vein, and
prosthetic grafts. Cases were excluded from evaluation
(n ¼ 1522) because of acute ischemia (n ¼ 270), missing
indication (n ¼ 128), bilateral (n ¼ 131) and concomitant
procedure (n ¼ 860), death at discharge (n ¼ 30), and
missing bypass graft patency information (n ¼ 17). The
most common concomitant procedure excluded was com-
mon femoral endarterectomy (n ¼ 663). We also excluded
86 LEBs by surgeons who performed fewer than 10 cases
per study period within VSGNE (23 surgeons) and were
therefore unable to be classiﬁed with respect to their CIM
strategy. The ﬁnal study cohort included 2032 LEBs per-
formed by 48 surgeons.
Outcome and variable deﬁnitions. Demographics,
pre-existing medical comorbidities, and index operation
details were reviewed. More than 100 clinical and de-
mographic variables were collected prospectively and
entered into the VSGNE database for each procedure.18
Deﬁnitions of medical comorbidities in VSGNE have been
previously described elsewhere.18 CIM was deﬁned as
intraoperative angiography or duplex ultrasound scan per-
formed during LEB. The decision to use CIM, interpreta-
tion of CIM ﬁndings, and decision for re-exploration were
left to the discretion of individual surgeons and were not
evaluable in this study. Main outcomes measured included
primary bypass graft patency at discharge and at 1 year.
Statistical analysis. Our study consisted of two main
analyses. First, the outcomes of LEB patients were
compared on the basis of whether CIM was performed.
This analysis was performed for the entire study cohort
(n ¼ 2032) as well as for patients treated with only autog-
enous bypass grafts (n ¼ 1525). In the second analysis, sur-
geons were categorized into two groups on the basis of the
percentage of LEB cases in which the surgeon elected to
perform CIM. Patients with both autologous and pros-
thetic LEBs were included in this analysis. Those surgeons
who performed CIM in$80% of LEBs were categorized asroutine users of CIM, whereas those who performed CIM
in <80% of LEBs were characterized as selective CIM users
(Fig 1). Routine users were then compared with selective
users on the basis of aggregated surgeon outcomes mea-
sures. Additional analyses were done after dividing the
surgeons into tertiles based on the percentages of CIM
performed. Outcomes of patients who had LEB performed
by surgeons in the upper tertile were compared with those
of patients who had LEB performed by surgeons in the
lower tertile.
Baseline demographic characteristics were compared
by c2 test for categorical variables and Student t-test for
continuous variables. Kaplan-Meier curves were con-
structed for the 1-year primary bypass graft patency. Multi-
variable logistic regression was used to evaluate factors
associated with performance of CIM during LEB and fac-
tors associated with discharge and 1-year graft patency.
These associations were expressed as adjusted odds ratios
(AORs) with corresponding 95% conﬁdence intervals
(CIs). Multivariable Cox proportional hazards models
were used to evaluate the effect of CIM on primary graft
patency loss, reintervention, and major amputation. These
associations were expressed as adjusted hazard ratios
(AHRs) with corresponding 95% CI. Gamma regression
model was used to evaluate the effect of CIM on hospital
length of stay, and the associations were expressed as
adjusted mean ratios with corresponding 95% CI. In all
patient-level multivariable analyses, we initially included
the following factors on the basis of the group difference
at .2 a level as well as factors that were determined to be
relevant clinically: patient age, race, smoking, hypertension,
diabetes, end-stage renal disease (ESRD), indication for
surgery (claudication vs critical limb ischemia), urgency,
graft origin, graft recipient, and type of conduit. Backward
elimination procedure with exit a level set at .2 was then
used to construct parsimonious models.
For our second outcome analysis, multivariable Poisson
regression models were used to compare aggregated counts
of graft patency failure based on the surgeon’s CIM
Table I. Demographic, patient, and operative characteristics of patients who did and did not undergo completion
imaging (CIM) during lower extremity bypass (LEB)
Characteristic Overall (N ¼ 2032) CIM (n ¼ 1368) No CIM (n ¼ 664) P value
Demographic
Age, years 68.2 6 11.9 68.5 6 12 67.5 6 11.8 .08
Male gender 1386 (68.2) 936 (68.4) 450 (67.8) .80
White race 1999 (99.1) 1347 (99.3) 652 (98.6) .13
Smoking
Never 378 (18.6) 264 (19.3) 114 (17.2) .02
Prior 890 (43.9) 619 (45.3) 271 (40.9)
Current 761 (37.5) 483 (35.4) 278 (41.9)
Medical comorbidity
Hypertension 1748 (86) 1186 (86.7) 562 (84.6) .22
Diabetes mellitus 1064 (52.4) 742 (54.2) 322 (48.5) .02
Coronary artery disease 768 (37.8) 527 (38.5) 241 (36.4) .38
Congestive heart failure 331 (16.3) 214 (15.6) 117 (17.6) .28
Chronic pulmonary disease 525 (25.9) 349 (25.5) 176 (26.5) .63
ESRD 157 (7.7) 121 (8.8) 36 (5.4) .01
Aspirin 1436 (70.7) 961 (70.2) 475 (71.5) .57
Clopidogrel 171 (8.4) 114 (8.3) 57 (8.6) .87
Statin 1251 (61.6) 831 (60.8) 420 (63.3) .28
Previous bypass 657 (32.3) 445 (32.5) 212 (31.9) .80
Creatinine, mg/dL 1.5 6 1.5 1.5 6 1.6 1.5 6 1.3 .28
Procedure detail
Indication
Claudication 544 (26.8) 340 (24.9) 204 (30.7) .001
Rest pain 515 (25.3) 336 (24.6) 179 (27)
Tissue loss 973 (47.9) 692 (50.6) 281 (42.3)
Urgency
Elective 1673 (82.3) 1150 (84.1) 523 (78.8) .002
Urgent 345 (17) 213 (15.6) 132 (19.9)
Emergent 14 (0.7) 5 (0.4) 9 (1.4)
Anesthesia
Spinal 330 (16.2) 231 (16.9) 99 (14.9) .49
Epidural 138 (6.8) 90 (6.6) 48 (7.2)
General 1563 (77) 1047 (76.5) 516 (77.8)
Graft origin
CFA, profunda, or SFA 1767 (88.8) 1209 (89.6) 558 (87.2) .11
Above- and below-knee PA 222 (11.2) 140 (10.4) 82 (12.8)
Graft recipient
Above- and below-knee PA 1132 (55.8) 688 (50.3) 444 (67.1) <.001
Tibioperoneal trunk, tibial or pedal artery 898 (44.2) 680 (49.7) 218 (32.9)
Conduit type
GSV 1364 (67.1) 979 (71.6) 385 (58) <.001
Single segment 1329 (65.4) 950 (69.4) 379 (57.2)
Multiple segments 34 (1.7) 29 (2.1) 5 (0.8)
Arm vein 161 (7.9) 125 (9.1) 36 (5.4)
Prosthetic 507 (25) 264 (19.3) 243 (36.6) <.001
CFA, Common femoral artery; ESRD, end-stage renal disease; GSV, great saphenous vein; PA, popliteal artery; SD, standard deviation; SFA, superﬁcial
femoral artery.
Continuous data are presented as mean 6 standard deviation and categorical data as number (%).
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tile vs lower tertile group) after adjustment for smoking,
indication for surgery, graft origin, graft recipient, and
type of conduit. These associations were expressed as rate
ratios (RR) with corresponding 95% CI.
Analysis was performed with commercially available
software (SAS 9.2; SAS Institute Inc, Cary, NC), and
P < .05 was deﬁned as statistically signiﬁcant.
RESULTS
Use of CIM during LEB. Completion study was per-
formed in 67% of patients (1368 LEBs). Seventy-twopercent of autogenous grafts (1104 LEBs) and 52% of
prosthetic grafts (264 LEBs) had CIM performed during
surgery. The majority of CIM used was arteriography
(89%), whereas duplex ultrasound was performed in 11% of
cases. Demographic, clinical, and operative characteristics
were compared between patients with LEB performed with
and without CIM (Table I). Patients with diabetes, ESRD,
and operation performed for critical limb ischemia were
more likely to have CIM performed during their LEB.
CIM was performed more often during elective surgery,
when the outﬂow vessel was a tibioperoneal trunk or tibial
or pedal artery, and when the great saphenous vein (GSV)
Fig 2. Kaplan-Meier curves of primary bypass graft patency
among patients treated with lower extremity bypass (LEB) per-
formed with or without completion imaging (CIM).
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analysis, primary bypass graft patency at discharge and at
1 year was similar in LEB procedures performed with or
without CIM (Fig 2). Primary bypass graft patency at
discharge and at 1 year was similar in LEB procedures
performed with completion angiography and duplex ul-
trasound (data not shown).
In multivariable analysis, no signiﬁcant differences were
found in discharge (AOR, 1.1; 95% CI, 0.7-1.7; P ¼ .64)
and 1-year (AOR, 0.9; 95% CI, 0.7-1.2; P ¼ .47) primary
bypass graft patency on the basis of whether CIM was per-
formed during LEB (Table II). Hospital lengths of stay
were similar between both groups (adjusted mean ratio,
1.1; 95% CI, 1.0-1.1; P ¼ .07). One-year mortality
(AHR, 1.0; 95% CI, 0.7-1.4; P ¼ .91), major amputation
(AHR, 1.5; 95% CI, 0.9-2.4; P ¼ .14), and reintervention
(AHR, 1.0; 95% CI, 0.7-1.5; P ¼ .92) were similar for
LEBs performed with and without CIM.
Factors associated with use of CIM in the multivariable
regression model included ESRD (AOR, 1.7; 95% CI, 1.1-
2.6; P ¼ .01), elective surgery (AOR, 2.6; 95% CI, 1.4-4.8;
P ¼ .002), popliteal artery origin (AOR, 0.5; 95% CI, 0.3-
0.7; P < .001), tibioperoneal trunk or tibial or pedal artery
bypass target (AOR, 1.8; 95% CI, 1.4-2.3; P < .001), and
use ofGSVas conduit (AOR,2.0; 95%CI, 1.6-2.5;P< .001).
Use of CIM in autogenous LEB. Additional analysis
was performed in LEB with autogenous graft (n ¼ 1525
LEBs). There was no signiﬁcant difference for primary
bypass graft patency at discharge (94.5% vs 94.5%; P ¼
.962) and 1 year (66.2% vs 68.5%; P ¼ .494) for LEBs per-
formed with and without CIM (Supplementary Table I,
online only). Multivariable analysis revealed no signiﬁcant
difference in discharge patency (AOR, 1.1; 95%CI, 0.7-1.8;
P ¼ .67) and 1-year patency (AOR, 1.1; 95% CI, 0.8-1.5;
P ¼ .62) based on whether CIM was performed. Factors
associated with CIM in autologous LEBs were elective
surgery (AOR, 3.0; 95% CI, 1.5-5.9; P ¼ .002), use of
popliteal artery as origin (AOR, 0.5; 95% CI, 0.4-0.7;P < .001), and tibioperoneal trunk or tibial or pedal artery
bypass target (AOR, 1.6; 95% CI, 1.3-2.1; P < .001).
Surgeon CIM strategy. Sixteen surgeons who per-
formed 36.7% (1076) of the LEBs performed CIM in
$80% of LEB procedures and were classiﬁed as routine
CIM users, whereas 32 surgeons who performed 63.4%
(1860) of the operations were classiﬁed as selective CIM
users. Overall, 20 surgeons (41.7%) performed CIM in
less than 60% of their LEBs (Fig 1). Twenty-six surgeons
(54%) performed both angiography and duplex ultrasound
during their LEBs. Among these surgeons, 14 (54%) used
angiography more frequently than duplex ultrasound, nine
(35%) used duplex ultrasound more frequently, and three
(11%) used them equally frequently. The surgeon’s case
load during the study period, indication for surgery, bypass
graft origin, and graft recipient were similar between LEBs
performed by routine and selective CIM users (Table III).
Routine CIM users performed a higher number of LEBs
with the GSV as a conduit compared with selective CIM
users. In bivariate analysis, there was no difference in pri-
mary bypass graft patency at discharge (routine, 95%, vs
selective, 96%; P ¼ .21) and 1 year (71.8% vs 68.2%; P ¼
.09) in LEBs performed by these two groups of surgeons.
In multivariable analysis, the surgeon’s strategy of per-
forming routine vs selective CIM was not associated with
primary graft patency at discharge (RR, 0.8; 95% CI, 0.6-
1.1; P ¼ .31) and at 1-year follow-up (RR, 1.1; 95% CI,
0.9-1.2; P ¼ .56) (Table III). Among selective CIM users,
factors associated with performance of CIM during LEB
included ESRD, elective LEB, tibial or pedal outﬂow ar-
tery, and arm vein and GSV conduit (Table IV and
Supplementary Table II, online only).
We performed additional analyses evaluating the out-
comes of surgeons in the upper tertile and lower tertile based
on percentages of CIM performed in their LEBs: primary
bypass graft patency at discharge (upper tertile, 95.8%, vs
lower tertile, 95.6%; P ¼ .86) and 1 year (66.6% vs 70.1%;
P ¼ .43). In multivariable analysis, discharge graft patency
(RR, 1.0; 95% CI, 0.5-1.8; P ¼ .95) and graft patency at
1 year (RR, 1.2; 95% CI, 0.8-1.6; P ¼ .39) were similar in
LEBs performed by these two groups of surgeons.
DISCUSSION
Our study demonstrates signiﬁcant variability in the
CIM strategy used by surgeons performing LEB inNewEn-
gland. In 67% of LEB procedures, CIMwas performed, and
in the majority of cases, intraoperative angiography was the
imaging modality of choice. CIM was performed in 70% of
autogenous grafts and in more than half of prosthetic grafts.
One third of the 48 surgeons included in this study per-
formed CIM after LEB on a routine basis. CIM after LEB
and the surgeon’s strategy of routine CIM use were not
associated with improvement in bypass graft patency at
discharge or at 1 year.
Early bypass graft failure can be caused by technical error,
poor conduit quality, insufﬁcient arterial inﬂow, inadequate
outﬂow target artery, and blood hypercoagulability.5,19 It is
associated with signiﬁcantly decreased graft patency and
Table II. Multivariable analysis of the association between completion imaging (CIM) and primary bypass graft patency
during lower extremity bypass (LEB)
Adjusted
estimatea
95% Lower
conﬁdence limit
95% Upper
conﬁdence limit P value
Discharge patency
CIM 1.11 0.72 1.70 .64
Age 1.01 0.99 1.03 .17
Hypertension 1.59 0.95 2.66 .08
Indication for surgery:
claudication vs critical limb ischemia
1.54 0.89 2.66 .12
Graft recipient: popliteal vs tibial or pedal artery 2.86 1.79 4.53 <.001
Conduit type
GSV vs prosthetic 1.43 0.86 2.38 .17
Arm vein vs prosthetic 0.83 0.41 1.69 .61
Autologous vs prosthetic 1.09 0.64 1.88 .75
One-year patency
CIM 0.90 .68 1.20 .47
Age 1.01 1.0 1.02 .06
Indication for surgery:
claudication vs critical limb ischemia
1.52 1.11 2.07 .01
Graft recipient: popliteal vs tibial or pedal artery 2.12 1.59 2.81 <.001
Conduit type
GSV vs prosthetic 1.21 0.88 1.66 .24
Arm vein vs prosthetic 0.78 0.48 1.31 .36
Autologous vs prosthetic 0.98 0.68 1.40 .90
Patency loss hazard
CIM 0.97 0.74 1.28 .83
Hypertension 0.72 0.52 1.01 .06
Graft recipient: popliteal vs tibial or pedal artery 0.48 0.36 0.64 <.001
Conduit type
GSV vs prosthetic 0.69 0.51 0.94 .02
Arm vein vs prosthetic 0.97 0.62 1.52 .89
Autologous vs prosthetic 0.82 0.58 1.15 .24
AOR, Adjusted odds ratio; GSV, great saphenous vein; HR, hazard ratio.
aAOR for initial patency and 1-year patency and adjusted HR for patency loss.
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tion, major amputation, and death.20-22 Avoidance of early
graft failure has led some surgeons to perform CIM,
including arteriography and duplex ultrasound, to ensure
technical adequacy of LEB.5-8,10,11,16,19 Multiple studies
have demonstrated excellent results in infrainguinal LEB
performed with either routine completion angiography7,16
or duplex ultrasound.10,11,13,23
Some studies have questioned the role of routine
CIM.15,17 In their prospective trial evaluating 54 infrain-
guinal LEBs, Blankensteijn et al15 demonstrated that
continuous waveform Doppler is the best method to detect
intraoperative technical problems. The authors stated that
routine intraoperative angiography was not necessary
when Doppler insonation and palpation of the graft indi-
cated a technically adequate bypass graft.15 In addition,
not all abnormalities noted on a completion angiogram
are clinically signiﬁcant and, as such, may not affect long-
term outcomes of the bypass graft.16,17 Others have also
demonstrated that CIM added little additional information
to standard evaluation techniques, especially when preop-
erative angiography was performed. Furthermore, CIM
has been demonstrated to be associated with increased
costs and resource use.17In this study, CIM was performed in two thirds of
autogenous grafts and in more than half of prosthetic
grafts. Other studies have similarly evaluated CIM in
LEB with prosthetic grafts.7,15,24,25 To minimize potential
bias, we performed analysis for the entire study cohort as
well as for autogenous LEBs after exclusion of prosthetic
conduits. The results were similar in that CIM did not
improve bypass patency at discharge and 1 year for autog-
enous or prosthetic bypass grafts. The factors that promp-
ted surgeons to perform CIM during LEB with use of an
autogenous conduit were also similar and included elective
surgery, popliteal artery as the origin, and tibioperoneal
trunk or tibial or pedal artery as the bypass target.
In this study, we classiﬁed surgeons who performed
CIM in $80% of LEBs as routine users and those who per-
formed CIM in <80% as selective users. The outcomes of
patients who had their LEBs performed by these two
groups of surgeons were compared. Routine use of CIM
did not improve bypass graft patency at discharge or at
1 year. The distribution of surgeons based on percentage
of CIM performed in their bypasses was not bimodal in na-
ture (Fig 1). Around 40% of surgeons performed CIM in
less than 60% of their LEBs, and 37% of surgeons per-
formed CIM in more than 80% of LEBs. The cutoff of
Table III. Surgeon’s caseload and characteristics of lower extremity bypass (LEB) based on completion imaging (CIM)
Surgeon characteristic
Selective CIM
(n ¼ 32), No. (%)
Routine CIM
(n ¼ 16), No. (%) P value
Total caseload
10-20 8 (25) 5 (31.3) .45
21-50 12 (37.5) 4 (25)
51-100 9 (28.1) 3 (18.8)
>100 3 (9.4) 4 (25)
LEB performed by
selective CIM user (n ¼ 1860), No. (%)
LEB performed by
routine CIM user (n ¼ 1076), No. (%) P value
Characteristic
Smoking
Never 319 (17.2) 160 (14.9) .02
Prior 802 (43.2) 521 (48.5)
Current 735 (39.6) 394 (36.7)
ESRD 125 (6.7) 112 (10.4) <.001
Urgency <.001
Elective 1447 (77.8) 948 (88.1)
Urgent or emergent 413 (22.2) 128 (11.9)
Indication
Claudication 508 (27.3) 285 (26.5) .25
Rest pain 490 (26.3) 260 (24.2)
Tissue loss 862 (46.3) 531 (49.3)
Graft origin
CFA, profunda, or SFA 1667 (91.3) 952 (91.2) .92
Above- or below-knee PA 159 (8.7) 92 (8.8)
Graft recipient
Above- or below-knee PA 1143 (61.5) 618 (57.5) .03
Tibioperoneal trunk,
tibial or pedal artery
715 (38.5) 457 (42.5)
Conduit type
GSV 1178 (63.3) 734 (68.2) <.001
Arm vein 125 (6.7) 96 (8.9)
Prosthetic 557 (29.9) 246 (22.9)
CFA, Common femoral artery; ESRD, end-stage renal disease; GSV, great saphenous vein; PA, popliteal artery; SFA, superﬁcial femoral artery.
Table IV. Multivariable analysis of factors associated with performance of completion imaging (CIM) by surgeon’s
strategy of selective CIM
AOR 95% Lower conﬁdence limit 95% Upper conﬁdence limit P value
ESRD 3.09 1.23 7.77 .02
Elective vs urgent or emergent 1.37 1.02 1.84 .03
Graft recipient: popliteal vs
tibial or pedal artery
0.59 0.45 0.77 <.001
Graft vein type: arm vein vs none 2.12 1.23 3.67 .01
Graft vein type: GSV vs none 1.52 1.14 2.04 .01
AOR, Adjusted odds ratio; ESRD, end-stage renal disease; GSV, great saphenous vein.
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choose 80% as the cutoff value was made after performing
a careful threshold analysis. Cutoff threshold analyses were
performed with different potential cutoff points, including
90% vs 10%, upper vs lower tertile, and ﬁrst quartile vs
fourth quartile. In each of these analyses, the results ob-
tained were similar, demonstrating no difference in out-
comes between patients operated on by surgeons using
routine vs selective CIM. In addition, after controllingfor potential confounders, including indication, type of
bypass, and conduit used, the surgeon’s strategy of per-
forming CIM routinely or selectively had no effect on
bypass graft patency at discharge or at 1 year.
CIM has an important role in LEB, and to better un-
derstand its use, we evaluated the factors that prompt selec-
tive users to perform CIM. These included ESRD, distal
bypass with tibial or pedal artery as the outﬂow target,
and autologous conduit with GSV or arm vein. Of note,
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their LEBs with prosthetic grafts. LEBs performed by sur-
geons who used selective CIM had similar bypass graft
patency at discharge and 1 year compared with routine
CIM users. Selective CIM users were also more likely to
perform CIM in elective settings. Our data suggest that
the surgeon’s strategy of performing CIM selectively is
effective and can be associated with decreased operating
time and resources.
There are important limitations to this study. This is an
observational study of a prospectively collected regional
database rather than a randomized controlled trial. The
surgeons in the study were classiﬁed into routine or selec-
tive CIM users on the basis of the percentage of CIM per-
formed in their LEBs. The cutoff of 80% in this study was
arbitrarily made and might not reﬂect the true practice
strategy of individual surgeons, but threshold analyses
revealed that the results do not change when different cut-
off values were tested. We were not able to determine the
relationship between CIM and an individual surgeon’s
experience. Our study is limited by the variables collected
within VSGNE, and therefore there may be potentially un-
accounted cofounders in our analyses. We were not able to
determine the frequency of abnormal CIM ﬁndings, the
numbers of grafts that were revised on the basis of CIM
ﬁndings, or the exact indication for performance of CIM
in selective users because of the inherent limitation of the
data set. The majority of CIM performed in this study
was angiography, and no surgeon performed angioscopy.
We were therefore unable to evaluate the efﬁcacy of angio-
scopy as CIM in LEB.
Despite these limitations, the utility of the VSGNE
database has been validated in other studies for patients un-
dergoing vascular procedures.26-29 Using this prospectively
collected database, we were able to study large numbers of
LEBs to evaluate the association of CIM with primary
bypass graft patency. We were also able to appraise sur-
geons’ preference of performing CIM routinely or selec-
tively and to demonstrate that the surgeon’s strategy of
performing routine CIM is not associated with improve-
ment in bypass graft patency.
CONCLUSIONS
Our study suggests that CIM does not improve short-
term and 1-year bypass graft patency in autogenous or
prosthetic infrainguinal LEBs. The surgeons’ strategies of
routine and selective CIM, especially in patients with
ESRD, LEB with autogenous conduit, popliteal artery
inﬂow, and distal target, are as effective for infrainguinal
LEB.
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Supplementary Table I (online only). Demographic, patient, and operative characteristics and bypass graft patency of
autogenous lower extremity bypass (LEB)
Characteristic Overall (N ¼ 1525) CIM (n ¼ 1104) No CIM (n ¼ 421) P value
Demographic
Age, years 67.9 6 12.1 68.1 6 12.1 67.5 6 11.9 .38
Male gender 1066 (69.9) 770 (69.7) 296 (70.3) .85
White race 1499 (99) 1087 (99.3) 412 (98.3) .14
Smoking
Never 303 (19.9) 220 (19.9) 83 (19.7) .76
Prior 667 (43.8) 488 (44.2) 179 (42.5)
Current 554 (36.4) 395 (35.8) 159 (37.8)
Medical comorbidity
Hypertension 1305 (85.6) 948 (85.9) 357 (84.8) .63
Diabetes mellitus 806 (52.9) 592 (53.6) 214 (50.8) .33
Coronary heart disease 550 (36.1) 403 (36.5) 147 (35) .59
Congestive heart failure 245 (16.1) 173 (15.7) 72 (17.1) .53
Chronic pulmonary disease 361 (23.7) 262 (23.8) 99 (23.5) .95
ESRD 122 (8) 97 (8.8) 25 (6) .17
Creatinine, mg/dL 1.5 6 1.6 1.5 6 1.6 1.5 6 1.4 .72
Aspirin 1067 (70) 775 (70.2) 292 (69.4) .76
Clopidogrel 128 (8.4) 89 (8.1) 39 (9.3) .47
Statin 916 (60.1) 651 (59) 265 (62.9) .16
Previous bypass 444 (29.1) 330 (29.9) 114 (27.1) .29
Creatinine, mg/dL 1.5 6 1.6 1.5 6 1.6 1.5 6 1.4 .72
Procedure detail
Indication
Claudication 369 (24.2) 250 (22.6) 119 (28.3) .06
Rest pain 381 (25) 276 (25) 105 (24.9)
Tissue loss 775 (50.8) 578 (52.4) 197 (46.8)
Urgency
Elective 1248 (81.8) 928 (84.1) 320 (76) <.001
Urgent 267 (17.5) 172 (15.6) 95 (22.6)
Emergent 10 (0.7) 4 (0.4) 6 (1.4)
Anesthesia
Spinal 237 (15.6) 189 (17.1) 48 (11.4) .02
Epidural 107 (7) 77 (7) 30 (7.1)
General 1180 (77.4) 838 (75.9) 342 (81.4)
Graft origin
CFA, profunda, or SFA 1301 (86.1) 960 (87.8) 341 (81.8) .004
Above- and below-knee PA 210 (13.9) 134 (12.2) 76 (18.2)
Graft recipient
Above- and below-knee PA 721 (47.3) 492 (44.6) 229 (54.5) .001
Tibioperoneal trunk, tibial or pedal artery 803 (52.7) 612 (55.4) 191 (45.5)
Graft vein type
GSV (single) 1329 (87.2) 950 (86.1) 379 (90.2) .06
GSV (multiple) 34 (2.2) 29 (2.6) 5 (1.2)
Arm vein 161 (10.6) 125 (11.3) 36 (8.6)
Outcome
Discharge primary patency 1441 (94.5) 1043 (94.5) 398 (94.5) .99
1-year primary patency 698 (66.7) 520 (66.2) 178 (68.5) .54
CFA, Common femoral artery; CIM, completion imaging; ESRD, end-stage renal disease; GSV, great saphenous vein; PA, popliteal artery; SD, standard
deviation; SFA, superﬁcial femoral artery.
Continuous data are presented as mean 6 standard deviation and categorical data as number (%).
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Supplementary Table II (online only). Demographic, patient, and operative characteristics of lower extremity bypass
(LEB) performed by selective completion imaging (CIM) surgeons
Characteristic Overall (N ¼ 1240) CIM (n ¼ 667) No CIM (n ¼ 573) P value
Demographic
Age, years, median and range 69 (25-96) 70 (25-95) 68 (26-96) .13
Male gender 833 (67.2) 449 (67.3) 384 (67) .95
White race 1221 (99.3) 658 (99.8) 563 (98.6) .02
Smoking
Never 240 (19.4) 137 (20.6) 103 (18) .05
Prior 517 (41.8) 291 (43.7) 226 (39.5)
Current 481 (38.9) 238 (35.7) 243 (42.5)
Medical comorbidity
Hypertension 1063 (85.7) 576 (86.4) 487 (85) .52
Diabetes 655 (52.8) 368 (55.2) 287 (50.1) .08
Coronary artery disease 473 (38.2) 262 (39.3) 211 (37) .41
Congestive heart failure 212 (17.1) 109 (16.3) 103 (18) .45
Chronic pulmonary disease 325 (26.2) 179 (26.8) 146 (25.5) .61
ESRD 82 (6.6) 54 (8.1) 28 (4.9) .07
Aspirin 860 (69.4) 452 (67.8) 408 (71.2) .20
Clopidogrel 108 (8.7) 52 (7.8) 56 (9.8) .23
Statin 765 (61.8) 405 (60.8) 360 (62.9) .45
Previous bypass 387 (31.2) 211 (31.6) 176 (30.7) .76
Creatinine, mg/dL 1.5 6 1.4 1.5 6 1.5 1.4 6 1.3 .757
Procedure detail
Indication
Claudication 333 (26.9) 165 (24.7) 168 (29.3) .104
Rest pain 327 (26.4) 173 (25.9) 154 (26.9)
Tissue loss 580 (46.8) 329 (49.3) 251 (43.8)
Urgency
Elective 971 (78.3) 534 (80.1) 437 (76.3) .110
Urgent 256 (20.6) 129 (19.3) 127 (22.2)
Emergent 13 (1) 4 (0.6) 9 (1.6)
Anesthesia
Spinal 194 (15.7) 114 (17.1) 80 (14) .025
Epidural 68 (5.5) 27 (4) 41 (7.2)
General 977 (78.9) 526 (78.9) 451 (78.8)
Graft origin
CFA, profunda, or SFA 1080 (88.5) 589 (89) 491 (87.8) .59
Above- and below-knee PA 141 (11.5) 73 (11) 68 (12.2)
Graft recipient
Above- and below-knee PA 709 (57.2) 335 (50.2) 374 (65.4) <.001
Tibioperoneal trunk, tibial or pedal artery 530 (42.8) 332 (49.8) 198 (34.6)
Graft vein type <.001
GSV (single segment) 797 (64.3) 451 (67.6) 346 (60.5)
GSV (multiple segments) 19 (1.5) 14 (2.1) 5 (0.9)
Arm vein 90 (7.3) 60 (9) 30 (5.2)
Prosthetic 333 (26.9) 142 (21.3) 191 (33.4)
CFA, Common femoral artery; ESRD, end-stage renal disease; GSV, great saphenous vein; PA, popliteal artery; SD, standard deviation; SFA, superﬁcial
femoral artery.
Continuous data are presented as mean 6 standard deviation and categorical data as number (%).
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